Lucid Diagnostics Inc. LUCD
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 26.74% | 51.69% | 25.65% | 3.33% | 19.16% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 26.74% | 51.69% | 25.65% | 3.33% | 19.16% |
| Cost of Revenue | -7.55% | 4.77% | -13.29% | 0.77% | -3.16% |
| Gross Profit | 107.25% | 48.96% | 62.45% | 5.08% | 37.30% |
| SG&A Expenses | 19.84% | 1.98% | 19.85% | 5.15% | 6.03% |
| Depreciation & Amortization | 0.00% | 0.00% | -0.94% | 0.00% | 0.00% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 13.77% | 0.41% | 14.32% | 0.81% | 3.11% |
| Operating Income | -12.45% | 2.99% | -13.22% | -0.56% | -1.72% |
| Income Before Tax | -163.28% | 48.31% | -40.94% | 15.96% | 59.66% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -163.28% | 48.31% | -40.94% | 15.96% | 59.66% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -163.28% | 48.31% | -40.94% | 15.96% | 59.66% |
| EBIT | -12.45% | 2.99% | -13.22% | -0.56% | -1.72% |
| EBITDA | -12.68% | 3.05% | -13.57% | -0.52% | -1.82% |
| EPS Basic | -0.88% | 67.77% | 37.38% | 60.87% | 65.09% |
| Normalized Basic EPS | 39.04% | 52.35% | 49.81% | 53.23% | 50.49% |
| EPS Diluted | -0.88% | 67.77% | 37.38% | 60.87% | 65.09% |
| Normalized Diluted EPS | 39.04% | 52.35% | 49.81% | 53.23% | 50.49% |
| Average Basic Shares Outstanding | 84.99% | 103.64% | 125.07% | 114.75% | 105.32% |
| Average Diluted Shares Outstanding | 84.99% | 103.64% | 125.07% | 114.75% | 105.32% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |